Global Assets Advisory’s iShares Biotechnology ETF IBB Stock Holding History

Global Assets Advisory’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$384K	Buy	2,020 +279	+16%	+$48K	0.08%	226
2026 Q1	$294K	Sell	1,741 -467	-21%	-$79.9K	0.08%	179
2025 Q4	$373K	Buy	2,208 +5	+0.2%	+$812	0.11%	191
2025 Q3	$318K	Sell	2,203 -390	-15%	-$53.2K	0.09%	200
2025 Q2	$331K	Sell	2,593 -4,722	-65%	-$580K	0.13%	150
2025 Q1	$866K	Buy	7,315 +5,258	+256%	+$713K	0.16%	122
2024 Q4	$273K	Buy	+2,057	New	+$289K	0.15%	126
2024 Q2	–	Sell	-481,413	Closed	-$3.52M	–	265
2024 Q1	$3.52M	Buy	+481,413	New	+$65.7M	0.16%	113
2023 Q4	–	Sell	-8,502	Closed	-$1.04M	–	85
2023 Q3	$1.04M	Sell	8,502 -60	-0.7%	-$7.63K	0.92%	28
2023 Q2	$1.09M	Buy	8,562 +137	+2%	+$17.8K	0.99%	30
2023 Q1	$1.12M	Sell	8,425 -111	-1%	-$14.5K	1.14%	21
2022 Q4	$1.12M	Sell	8,536 -1,455	-15%	-$188K	1.18%	19
2022 Q3	$1.28M	Buy	+9,991	New	+$1.24M	1.3%	17

Other funds holding IBB

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Commerce Bank Kansas City, Missouri $22.8B AUM 28.56% 1-Year Est. Return

Global Assets Advisory's IBB Position: Q2 2026 in Review

Global Assets Advisory increased its iShares Biotechnology ETF (IBB) stake by 16% in Q2 2026, buying an estimated $48K and bringing the position to 2,020 shares worth $384K. The position accounts for 0.08% of the portfolio, ranked #226.

Global Assets Advisory first reported a position in IBB in Q3 2022 and has held it in 13 quarters since. The position peaked at $3.52M in Q1 2024. 954 funds tracked by Wall St. Rank hold IBB as of Q2 2026.

Global Assets Advisory held 2,020 shares of iShares Biotechnology ETF worth $384K as of Q2 2026.
Global Assets Advisory bought 279 iShares Biotechnology ETF shares in Q2 2026, an estimated $48K.
iShares Biotechnology ETF made up 0.08% of Global Assets Advisory's portfolio in Q2 2026, its #226 holding.
Global Assets Advisory first reported a position in iShares Biotechnology ETF in Q3 2022 and has held it in 13 quarters since.
Global Assets Advisory's iShares Biotechnology ETF position peaked at $3.52M in Q1 2024.
954 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2026.

Based on Global Assets Advisory's 13F filing for Q2 2026, filed 27 Jul 2026.